HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy

Palbociclib, Medicine, Endocrine system, Oncology, Cancer, Breast cancer, Gynecology, Hormone receptor, Internal medicine, Metastatic breast cancer, Hormone